Valuation (0%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 4.65 |
| PEG Ratio (TTM) | N/A | -5.74 |
| P/S Ratio (TTM) | N/A | 1.04 |
| P/B Ratio (TTM) | N/A | 1.42 |
| P/FCF Ratio (TTM) | N/A | 9.79 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.91 |
| Price to 5YR AVG FCF Ratio | N/A | 4.23 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.06% | -1.07% |
| ROE (TTM) | -0.16% | 3.06% |
| Net Profit Margin (TTM) | -0.08% | -1.49% |
| ROIC 5YR AVG | N/A | 9.09% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | N/A | N/A |
| Revenue | 0.71% | -3.18% | N/A |
| Net Income | -74.96% | -111.32% | N/A |
| Cash Flow | 17.80% | -14.57% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.11 | 1.29 |
| Quick Ratio (TTM) | 0.60 | 1.29 |
| D/E Ratio (TTM) | 0.86 | 1.04 |
| Interest Coverage (TTM) | 2.79 | 4.34 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 0.15 | 1.25 |
| LTL to 5YR AVG FCF | N/A | 7.75 |
| Shares Outstanding Growth 5YR AVG | N/A | 7.36% |